Showing results (191-200 of 432) with videos related to

Sort By:
Pageof 44
Blood|May 9, 2008
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 studyBertrand Godeau, Raphael Porcher, Olivier Fain, et al.
American Journal of Hematology|June 11, 2013
Outcome of older patients with acute myeloid leukemia in first relapseClémentine Sarkozy, Claude Gardin, Nathalie Gachard, et al.
Journal of Hematology & Oncology|November 14, 2025
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohortJorge Cortes, Antonio Curti, Pierre Fenaux, et al.
British Journal of Haematology|May 16, 2020
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry GroupUrsula Rochau, Igor Stojkov, Annette Conrads-Frank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemiaPierre Fenaux, Ghulam J Mufti, Eva Hellström-Lindberg, et al.
Annals of Hematology|January 12, 2023
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST studyUlrich Germing, Pierre Fenaux, Uwe Platzbecker, et al.
Blood|May 15, 2004
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 studySylvie Castaigne, Sylvie Chevret, Eric Archimbaud, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2020
Multicenter Next-Generation Sequencing Studies between Theory and Practice: Harmonization of Data Analysis Using Real-World Myelodysplastic Syndrome DataSarah Sandmann, Aniek O de Graaf, Magnus Tobiasson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL GroupCecile Bally, Jehane Fadlallah, Guy Leverger, et al.
Oncotarget|November 16, 2017
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapyThomas Prebet, Thomas Cluzeau, Sophie Park, et al.
Pageof 44